US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.210
  • -0.050-2.21%
Close Jan 17 16:00 ET
  • 2.200
  • -0.010-0.45%
Post 20:01 ET
435.45MMarket Cap-3.30P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Esperion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.303M--
--2024/Q4-- / 63.058M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.303M--
--2024/Q4-- / 63.058M--
Nov 7, 20242024/Q351.632M / 51.714M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--

Unlock Free Earnings Estimates

Esperion Therapeutics Earnings Reports

  • Esperion Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:29 ET

  • Esperion Therapeutics | 8-K: Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update

    Nov 7, 2024 07:23 ET

  • Esperion Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12, 2024 16:12 ET

  • Esperion Therapeutics | 8-K: Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update

    Aug 12, 2024 07:26 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      71.43%

    • Hold

      14.29%

    • Sell

      14.29%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data